Animal study · rats

MOTS-c improved heart mitochondrial respiration in diabetic rats

Checked against the paper Animal studyPublished by PepVault

The takeaway

This rat study links MOTS-c to better glucose control and stronger heart mitochondrial respiration in diabetes, but it is early animal evidence only.

Kind
Animal study
Studied in
Rats
Published
2025
Journal
Front Physiol

What they tested

The team wanted to know whether MOTS-c treatment improves energy production by heart mitochondria, the cell's power units, in type 2 diabetes.

How the study was done

An animal study in rats made diabetic with a high-fat diet and low-dose streptozotocin, compared with healthy control rats. One diabetic group got daily MOTS-c injections at 15 mg/kg for 3 weeks, and heart tissue samples were tested for oxygen use, ATP (the cell's energy molecule) handling and ROS (reactive oxygen species) output.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking MOTS-c? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In rats, untreated diabetic animals had high blood sugar, poor glucose control and left ventricular hypertrophy (an enlarged main pumping chamber wall) compared with controls. Their heart mitochondria used less oxygen during oxidative phosphorylation (the main energy-making step), while ROS output and ATP production and breakdown did not change. Diabetic rats given MOTS-c had lower fasting glucose, better glucose control and less heart enlargement. Their heart mitochondria showed higher oxidative phosphorylation respiration, higher ROS levels and a lower rate of ATP breakdown when oxygen was cut off.

What it doesn’t show

This is a short, 3-week study in rats with a diet-and-drug model of diabetes, so it is not a human result. The mitochondrial tests were done on heart tissue samples, so the study does not show effects on heart pumping in living animals or people.

The paper

Pham et al. Mitochondria-derived peptide MOTS-c restores mitochondrial respiration in type 2 diabetic heart. Front Physiol. 2025.

The compound

More studies on MOTS-c

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking MOTS-c? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo